Maxigen Biotech Inc
TWSE:1783

Watchlist Manager
Maxigen Biotech Inc Logo
Maxigen Biotech Inc
TWSE:1783
Watchlist
Price: 41.9 TWD 0.12%
Market Cap: 3.7B TWD
Have any thoughts about
Maxigen Biotech Inc?
Write Note

Maxigen Biotech Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Maxigen Biotech Inc
Cash from Financing Activities Peer Comparison

Comparables:
G
1707
1731
4137

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Maxigen Biotech Inc
TWSE:1783
Cash from Financing Activities
-NT$36.2m
CAGR 3-Years
14%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
G
Grape King Bio Ltd
TWSE:1707
Cash from Financing Activities
-NT$1.7B
CAGR 3-Years
-59%
CAGR 5-Years
-2%
CAGR 10-Years
-9%
Maywufa Co Ltd
TWSE:1731
Cash from Financing Activities
NT$136.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Chlitina Holding Ltd
TWSE:4137
Cash from Financing Activities
-NT$690.6m
CAGR 3-Years
5%
CAGR 5-Years
-19%
CAGR 10-Years
N/A

See Also

What is Maxigen Biotech Inc's Cash from Financing Activities?
Cash from Financing Activities
-36.2m TWD

Based on the financial report for Jun 30, 2024, Maxigen Biotech Inc's Cash from Financing Activities amounts to -36.2m TWD.

What is Maxigen Biotech Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-7%

Over the last year, the Cash from Financing Activities growth was -3 615 000%. The average annual Cash from Financing Activities growth rates for Maxigen Biotech Inc have been 14% over the past three years , -7% over the past five years .

Back to Top